Park JY, Rha SW, Choi BG, Choi SY, Choi JW, Ryu SK, Lee SJ, Kim S, Noh YK, Akkala RG, Li H, Ali J, Kim JB, Lee S, Na JO, Choi CU, Lim HE, Kim JW, Kim EJ, Park CG, Seo HS, Oh DJ
PURPOSE: Angiotensin converting enzyme inhibitor (ACEI) and angiotensin receptor blocker (ARB) are associated with a decreased incidence of new-onset diabetes mellitus (NODM). The aim of this study was to compare...